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Abstract
A functionally rearranged TCR/3 (Tcrb) gene was isolated from a cloned human T helper cell
recognizing the CS.T3 epitope of Plasmodium falciparum with HLA-DR2. Transgenic mice were
generated by co-injection of the human gene together with the mouse Tcrb enhancer. Analysis of
transgenic mice shows that the functional Tcrb gene of xenogenic, i.e. human, origin exerts
allelic exclusion of endogenous Tcrb genes. Cytofluorometric analysis revealed expression of the
human TCR/3 chain on virtually all thymocytes and peripheral T cells together with endogenous
TCR/3 chains and CD3 components. No surface expression of mouse TCR/3 chain or
rearrangement of endogenous Tcr genes was detectable. Expression of the hybrid receptor
causes a reduction in the number of thymocytes and a bias for CD4+CD8" T cells in the thymus
as compared with non-transgenic littermates. Peripheral transgenic T cells mount a normal
proliferative response against allogeneic targets in mixed lymphocyte reactions. These results
show that a hybrid mouse/human TCR is able to pass positive and negative selection in the
thymus, and is functional in transgenic mice
Introduction
T cells recognize foreign antigens presented by self MHC class I
or class II molecules with the help of highly diverse, but clonally
distributed TCRs (for review see 1). TCRs are composed of
variable a and /3 chains associated with non-variant polypeptides
of the CD3 complex. The diversity of the TCRa and /3 chains is
generated somatically in T cells by rearrangement of distinct germ
line gene segments. During maturation of thymocytes the T cell
repertoire is subjected to positive and negative selection in the
thymus to render it functional and self-tolerant (2,3).
Transfection experiments have previously demonstrated that
a TCRa/3-CD3 complex containing xenogeneic polypeptide
chains can be expressed on the surface of human cells and
mediate T cell activation (4,5). In particular, human Jurkat cell
variants with inactive Tcra or b genes were transfected with
functionally rearranged mouse Tcra or b genes to replace the
inactivated subunit and shown to express hybrid mouse
a-human /3 and human a-mouse /3 heterodimers associated
with the human CD3 complex on the surface. Following ligand
binding, the hybrid receptors could mediate transmembrane
signals as measured by lymphokine secretion. More recently in
transgenic mice, a hybrid TCR-CD3 complex containing a
human CD3e chains was shown to be expressed on mouse T
cells and to be able to transduce activation signals (6).
Transgenic mice with functionally rearranged Tcr genes have
proven to be an excellent model to study T cell maturation and
repertoire selection (7,8). Introduction of functionally rearranged
mouse Tcrb genes into the germline of mice was shown to lead
to suppression of endogenous variable (Ve) gene segment
rearrangement (9-12). Whereas allelic exclusion was found to
strictly apply to the Tcrb locus, it seems that rearrangement of
the Tcra locus is controlled in a different way. Several T cell clones
have been described which contain two productively rearranged
Tcra alleles (13-17).
Here we demonstrate that a functionally rearranged human
Tcrb gene can be expressed on T cells of transgenic mice and
is able to suppress endogenous V0 gene segment rearrange-
ment. T cells bearing hybrid TCRs, consisting of the transgenic
human /3 chain associated with mouse a chains and the CD3
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components, can mature in transgenic mice and form a T cell
repertoire with an apparently normal frequency of alloreactive
cells.
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Methods
Generation of transgenic mice
Constructs were injected into zygotes of (C57BL/6xDBA/2)F,
mice as described (18,19). Founders were backcrossed with
strain C57BL/6J to establish transgenic lines B6-Tg58 and
B6-Tg62. Screening for transmission of the transgene in the
offspring was performed either by Southern blot analysis using
a 32P-labelled fragment of the human V05.1 segment as a probe
or by the polymerase chain reaction (PCR), essentially as
described elsewhere (20). The 5' primer used to detect the
transgene was specific for the 3' end of the human V^S.I
segment (CCAGTAAAGGCTGGAGTCAC) and the 3' primer was
specific for the human J31.2 region (TACAACGGTTAACCT-
GGTCC).
PCR
Oligonucleotides specific for sequences of the murine Ve
segments 2,6, 8.3 and 14 were used as 5' primers together with
an oligonucleotide recognizing a sequence 3' of ^2.6 as a 3'
primer at final concentrations of 1 mM each (21). Depending on
the primers used, the annealing temperature varied from 50 to
65°C and the magnesium concentration from 1 to 2 mM. PCR
was routinely performed with 25 cycles using 2 U Taq-Poly-
merase (Cetus) and 100 ng genomic DNA isolated from relevant
organs or cells before separating the amplified fragments on
agarose gels and transferring them to a nylon membrane (Zeta-
Probe, Bio-Rad Laboratories, Richmond, CA) by vacuum blotting.
DNA probes
For detection of the transgene we used a 300 bp EcoRV - HincW
fragment of the human V05.1 gene segment. A 1.4 kb Pst\
fragment specific for mouse DS1 was used to analyze D 3 - J 0
rearrangements, while a 1.2 kb EcoRI - C/al fragment covering
the mouse J02 cluster was applied to detect V 0 -D 3 J 0
rearrangements after PCR amplification (22). All probes were
labelled to high specific activity with [32P]dCTP by random
primer extension.
Cytofluorometric analysis
Preparation of T cells and analysis by flow cytometry was
essentially as described (19). Briefly, thymus and lymph nodes
were homogenized, and the cells recovered and washed twice
in PBS/5% FCS/0.1% NaN3. Samples of 106 cells were stained
in the same buffer at 4°C with optimal concentrations of
antibodies. After two further washes, 105 cells were analyzed
using a FACScan cytometer (Becton-Dickinson, Mountain View,
CA). Data were processed with the FACScan research software.
In order to make surface antigens accessible to the antibody /3F1,
cells were fixed prior to staining with 10 volumes of a freshly
prepared 1 °/o solution of formaldehyde in PBS at room tempera-
ture. After 15 min incubation, cells were washed twice with PBS.
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Fig. 1. Functionally rearranged Tcrb gene from the T helper cell clone
MG-30. Schematic representation of the Tcrb construct used for the
generation of transgenic mouse lines Tg58 and Tg62. The black box
indicates the human V^5.1 segment functionally rearranged to D^1 and
J01.2 gene segments. The striped box represents the human C^1
segment. L: leader; "location of a non-functional leader sequence. H:
H/ndlll; R: EcoRV; E: EcoRI.
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Fig. 2. Suppression of rearrangements of endogenous V^8.3 gene
segments in transgenic mice. Southern hybridization of PCR amplified
fragments using DNA from transgenic and non-transgenic thymocytes
from control littermates. The 5' primer was specific for V^8.3 and the 3'
primer specific for a sequence 3' of Jfl2. The probe for hybridization was
specific for Jg2. There is no detectable signal with DNA from transgenic
thymocytes, while V^8.3 rearrangements to all six JB2 segments are
clearly visible in the non-transgenic control.
Antibodies
Cells were stained with the following antibodies: anti-human pan-
TCR/3 (J8F1, T-Cell sciences, Cambridge, MA), anti-mouse
CD4-phycoerythrin(PE; L3T4, Becton-Dickinson), anti-mouse
CD8-FITC (Lyt-2, Becton-Dickinson), anti-mouse CD3e-
biotinylated (145-2C11, (23)), anti-mouse pan-TCR/3 (H 57-597,
(24)), anti-mouse Ve2 (B20.6.5, (25)), anti-mouse Vp3 (KJ 25,
(26)), anti-mouse V,j6 (44-22-1, (27)), and anti-mouse V ^ (F23.1,
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Fig. 3. (a) Expression of the human TCR/3 chain on thymocytes and lymph node T cells. Cytofluorometric analysis of fixed thymocytes (left) and
lymph node cells (right) from transgenic and non-transgenic mice. All thymocytes and peripheral T cells from transgenic mice were stained with
the pan-human TCR/3-specific antibody /3F1. The brightly stained population in the right panels are B cells which were directly stained by the second
reagent (anti-lg - FITC). (b) Expression of endogenous TCR/3 chains on thymocytes. Staining of transgenic and non-transgenic thymocytes with the
pan-mouse TCR/3 chain-specific antibody H57-597. No mouse TCR/3 chains are expressed on thymocytes transgenic for the human TCR/3 chain.
(28)). Secondary reagents were either FITC-labeled anti-mouse
Ig (Silenus Laboratories, Victoria, Australia) or PE-labeled
streptavidin (Becton-Dickinson).
Mixed lymphocyte reaction (MLR)
Purified spleen and lymph node cells (2.5x105/well) from
transgenic B6-Tg58 or B6-Tg62 animals and non-transgenic
controls were co-cultured in triplicate with 106 irradiated
syngeneic or allogeneic spleen cells as stimulators for 24, 48,
or 72 h. Addition of 1 pC\ of [3H]thymidine (Amersham,
Arlington Heights, IL) to each well was 20 h before harvesting
and measuring the [3H]thymidine uptake by liquid scintillation
counting.
ed human Tcrb gene together with a 5.5 kb fragment carrying
the mouse Tcrb enhancer (29). The mouse enhancer was co-
injected to ensure expression of the human transgene in T cells
at a high level. Both fragments were injected in equimolar
amounts into zygotes from (C57BL/6 x DBA/2JF, mice. Of the
four founder mice obtained, two did not transmit the transgenes
to their offspring. Of the others, transgenic lines B6-Tg58 and
B6-Tg62 were established by backcrossing with C57BL/6 mice.
Southern blot analysis revealed that the transgenes had in-
tegrated in 1 - 2 and - 1 0 copies respectively. The human Tcrb
gene was found to co-segregate with the enhancer transgene,
meaning that both had integrated into the same chromosomal
site.
Results
Isolation of a functionally rearranged human Tcrb gene
We used the cloned human T helper cell MG-30, recognizing
the CS.T3 epitope (amino acids 378-398) of the circumsporo-
zoite protein of Plasmodium falciparum in association with the
HLA class II molecule DR2, to isolate a human Tcrb gene.
Screening of EMBL3 genomic libraries made from this clone us-
ing Cg probes yielded full length clones containing the
functionally rearranged Tcrb gene. A 10.5 kb EcoRI genomic
fragment which contains a functionally rearranged V05.1 gene
segment joined to Dfi1 and J01.2 gene segments was sub-
cloned into pUC 19 (Fig. 1). About 500 bp upstream of the
N/,,5.1 leader exon, a second leader sequence was identified,
which is non-functional due to a mutation of the splice donor site.
Generation of transgenic mice
Transgenic mice were generated by microinjection of the 10.5 kb
genomic EcoRI fragment containing the functionally rearrang-
The human Tcrb transgene exerts allelic exclusion of endogenous
mouse Tcrb genes
Endogenous D 0 - J e rearrangements were assayed in
thymocytes of transgenic mice by Southern blot analysis. Similarly
to a functional murine Tcrb transgene (9), the human Tcrb
transgene did not inhibit endogenous D 0 - J g rearrangements
(data not shown).
Endogenous Vp-DgJ3 rearrangements were analyzed by
PCR with primers specific for different V3 gene segments (see
Methods). As shown in Fig. 2, six fragments were amplified when
DNA from non-transgenic thymocytes and a primer pair specific
for Vg8.3 and 3' J^2 sequences were used. These six fragments
correspond to rearrangements of V^8.3 gene segments of one
of each of the six Jff2 segments. No Vfl8.3 rearrangements,
however, were detectable in thymocytes from transgenic mice.
Analogous results were obtained with primers specific for V02,
V36, and V^14 regions (not shown). This shows that the human
transgene is able to completely suppress endogenous \le-
rearrangements.
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Fig. 4. Surface expression of the human TCR/3 chain. Thymocytes from
transgenic mice were fixed and stained with the antibody 0F1 before or
after treatment with trypsin for 15 min. Thymocytes from non-transgenic
mice were used as control. The decrease in signal intensity after trypsin
treatment is clearly visible and even more pronounced after longer
incubation times.
The human Tcrb transgene is transcribed in a cell-type specific
way
Cell-type specific transcription of the human transgene was
analyzed by Northern blot hybridization (data not shown). In both
transgenic mouse lines, mature transcripts of 1.3 kb in size were
detected in transgenic thymus and to a lesser extent also in
spleen, but not in brain, heart, lung, kidney or bone marrow. A
low level of unspecific transcription was found in testes.
The human TCR/3 chain is expressed on the surface of transgenic
T cells
Attempts to immunoprecipitate the human 0 chain from the
surface of transgenic T cells using the antibody /3F1, specific for
a common determinant on human TCR/3 chains, were
unsuccessful. Cytofluorometric analysis, however, demonstrated
that the human /3 chain is expressed on virtually all T cells in
transgenic mice.
T cells were fixed with formaldehyde to allow the 0F1 antibody
to recognize its determinant on the human j3 chain (30). As shown
in Fig. 3(A), essentially all thymocytes and peripheral T cells from
transgenic mice were stained with /3F1 demonstrating expression
of the human 0 chain. To ensure that the determinant seen by
/3F1 is indeed located on the cell surface and not in the cytoplasm
exclusively, cells were gently trypsinized for different time intervals
prior to formaldehyde fixation and staining. Prolonged trypsiniza-
tion led to decreasing signals as revealed by 0F1 and reached
control levels after 30 min of trypsinization, proving that the human
/3 chain is indeed expressed on the cell surface (Fig. 4).
Thymocytes from transgenic mice were also analyzed for the
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Fig. 5. Kinetics of MLR. Transgenic (T) and control (C) responder cells
were co-cultured with irradiated syngeneic (H^13) and allogeneic (H-2S
and H-2d) spleen cells. [3H]thymidine incorporation was measured after
24 (black), 48 (grey) and 72 (striped) h.
expression of endogenous mouse TCR/3 chains with the antibody
H57-597 which detects a common determinant on mouse /3
chains. Whereas in normal mice ~3O°/o of thymocytes were
stained with this antibody, no staining above background levels
were obtained for transgenic thymocytes (Fig. 3B). In addition,
antibodies specific for different mouse V,, regions (V^2, Vg3, V^ ,
and V^)—covering together more than one third of the normal
mouse y0 repertoire—did not stain transgenic thymocytes (not
shown).
Transgenic thymocytes and peripheral T cells were also stained
with the antibody 145-2C11 specific for the e subunit of the murine
CD3 complex. No difference with respect to the number of
CD3+ T cells as well as the level of CD3 surface expression was
found in transgenic mice when compared with normal littermates
(not shown). Taken together, these results demonstrate that the
human TCR/3 chain is expressed on transgenic T cells in the
complete absence of mouse /3 chains.
The human transgenic 0 chain participates in the formation of
a functional TCR
Since the human /3 transgene exerts allelic exclusion of
endogenous mouse /3 genes and leads to the expression of a
human 0 chain on the surface of transgenic T cells in the absence
of detectable mouse /3 chains, it is reasonable to assume that
the human /3 chain is associated with mouse TCRa chains and
CD3 polypeptides. Are these hybrid receptors able to recognize
foreign antigens and to trigger T cell responses?
The function of transgenic T cells was assayed by their ability
to respond to allogeneic targets in mixed lymphocyte reactions
(MLRs). Splenocytes from SJL (H-2S, Mls-1b, Mls-23) and DBA/2
(H-2d, Mls-1a, Mls-2a) mice were used as stimulators. As seen
in Fig. 5, T cells from transgenic as well as control littermates
(H-2b, Mls-1b, Mls-2b) were indistinguishable in their ability to
recognize allogeneic target cells and to respond by proliferation.
Functional expression of a human TCR/3 gene 15
i
Q
O
control
9 x 10 thymocytes
transgenic
1 -3 x 10 thymocytes
CD8
Fig. 6. CD4/CD8 subpopulations of thymocytes. Two-color cytofluoro-
metric analysis of thymocytes for non-transgenic (upper panel) and
transgenic mice (lower panel). Numbers of quadrants give the relative
percentage of thymocyte subpopulations.
These results reveal that the frequency of alloreactive T cells is
as high in transgenic as in control animals. Thus the invariant
human TCR/3 chain together with a variable mouse TCRa chain
and murine CD3 molecules can form functional TCR in transgenic
mice.
Expression of the human transgene in H-2b mice affects
thymocyte differentiation
The accumulation of functional T cells in the periphery of
transgenic mice, expressing a mouse-human hybrid TCR
receptor, indicates that these receptors can pass positive and
negative selection in the thymus. The expression of the human
TCR/3 chain in transgenic mice, however, has a strong impact
on the number and phenotype of T cells in the thymus (Fig. 6).
Whereas normal littermates contain ~9x10 7 thymocytes, this
number is reduced to ~ 1 - 3 x 1 0 7 in transgenic mice.
Furthermore, a relative increase of CD4+ single-positive and a
decrease of CD4+CD8+ double-positive T cells were found. The
relative size of the CD4-CD8" and CD4~CD8+ subpopulations
remained unchanged.
In contrast to what was observed in the thymus, the periphery
of transgenic mice contained normal numbers of T cells and
CD4+ or CD8+ subpopulations. Also the number of B cells is
as in control littermates.
Discussion
Experiments using Tcrb transgenes in mice have shown that
allelic exclusion is a regulated rather than a stochastic event
(9-12). Here we demonstrate that a functional Tcrb transgene
of human origin is able to completely suppress V0-DgJe
rearrangements of the endogenous Tcrb loci in the mouse. Thus,
the mechanisms regulating allelic exclusion seem to be
conserved between mouse and man. Experiments with a mutant
Tcrb transgene showed that expression of the C region domain
is sufficient to induce allelic exclusion in transgenic mice (31).
The transcript by itself, however, had no effect. Analyses of mice
double transgenic for either a Tcrb minilocus and a functional
Tcrb gene (21), or two functional Tcrb transgenes (32), revealed
that allelic exclusion may operate at a level after gene
rearrangement.
Surface expression of the human TCR/3 chain was detected
with the pan-specific mAb /3F1 after fixation of T cells, which is
necessary to render the determinant accessible to the antibody.
The gradual elimination of the determinant by prolonged digestion
with trypsin clearly demonstrates that the human TCR/3 chain is
expressed on the cell surface. No antibody specific for the
variable region of the human transgene was available. The
antibody 42 1C1 (33), raised against the human V35.3 domain,
did not detect the V^ . I region encoded by our transgene.
By immunoprecipitation we could not give direct evidence for
a hybrid formation of the human TCR/3 chain with various mouse
TCRa chains, because the pan-human TCR/3 antibody /3F1
detects a hidden determinant of the TCR - CD3 complex on the
cell surface. This determinant is accessible to the antibody only
after fixation of the cells, which bears the risk of exposing intra-
cellular components. However, several observations argue for
the expression of a hybrid mouse a - human /3 TCR in our trans-
genic mice, (i) A prerequisite for T cell maturation in the thymus
is a complete TCRa/3 receptor. Although it has been shown in
Tcrb transgenic scidlscid mice (8,34) that TCR/3 chains can
appear on thymocytes at early stages of differentiation together
with an as yet non-characterized invariant molecule, such a
receptor cannot pass positive selection in the thymus, and, in
addition, would not explain the alloreactive responses observed
with peripheral T cells in our transgenic mice, (ii) All mature T
cells in the periphery express CD3, which is constitutively
co-expressed with the TCRa/3 receptor, (iii) In the complete
absence of endogenous TCR/3 chains, only the transgenic human
/3 chain can pair with endogenous a chains and associate with
mouse CD3 polypeptides on the surface of T cells. With human
T cell lines, the formation and functionality of such a human
TCR - CD3 complex, where the TCRa or /3 chain is replaced by
the corresponding mouse TCR chain, was demonstrated (4,5).
Although the requirements for the formation of a hybrid
mouse - human receptor seem to be met, this process might be
of lower efficiency, permitting less thymocytes to proliferate as
compared with normal mice. An alternative explanation for the
reduced number of thymocytes, however, could be an enhanced
negative selection of the transgenic T cells expressing a
monomorphic /3 chain. No change, however, was detected in
the number of T cells in lymph nodes. It appears that both pool
sizes are regulated independently.
The hybrid mouse - human receptor is functional in thymocyte
development. It appears to be able to interact with mouse MHC
molecules and transduce signals necessary for further maturation
to single-positive thymocytes. The relative enrichment of CD4 +
single-positive thymocytes might reflect an intrinsic affinity of the
human TCR/3 chain—which was derived from a class II restricted
cell—for mouse MHC class II molecules. A preferential develop-
ment of CD4+ T cells in transgenic mice expressing MHC class
ll-restricted TCRs was reported by Berg (35) and Kay (36);
however, not for a TCR/3 chain alone. When we made mice
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double transgenic for the TCRa and /3 chain of the T helper cell
MG-30, we found the same bias for CD4+ thymocytes as in the
single transgenic ones (unpublished results).
The invariant human TCR/3 chain reduces the TCR repertoire
in our transgenic mice by a factor of —10,000. Since the
frequency of alloreactive cells in the transgenic mice is still
comparable with control littermates, it seems that the antigenic
determinants on allogeneic cells are diverse enough to trigger
a restricted T cell repertoire to the same extent as a fully
developed one.
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